Loss of EGR3 is an independent risk factor for metastatic progression in prostate cancer.

Abstract excerpt

Identification of pro-metastatic genomic alterations is urgently needed to help understand and prevent the fatal course of prostate cancer. Here, we found that the transcription factor EGR3, located at chromosome 8p21.3, is a critical metastasis suppressor. Aberrant deletion of EGR3 was found in up to 59.76% (deep deletions, 16.87%; shallow deletions, 42.89%) of prostate cancer patients. In informatics analysis,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cell Movement
• Share to DNA Copy Number Variations
• Share to Epithelial-Mesenchymal Transition